These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 39139778)

  • 1. Simulating the effects of medicaid expansion on the opioid epidemic in North Carolina.
    Berghammer A; Adams JW; Khan S; Bobashev G
    Drug Alcohol Depend Rep; 2024 Sep; 12():100262. PubMed ID: 39139778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration of medication treatment for opioid-use disorder and risk of overdose among Medicaid enrollees in 11 states: a retrospective cohort study.
    Burns M; Tang L; Chang CH; Kim JY; Ahrens K; Allen L; Cunningham P; Gordon AJ; Jarlenski MP; Lanier P; Mauk R; McDuffie MJ; Mohamoud S; Talbert J; Zivin K; Donohue J
    Addiction; 2022 Dec; 117(12):3079-3088. PubMed ID: 35652681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-level impact of initiating pharmacotherapy and linking to care people with opioid use disorder at inpatient medically managed withdrawal programs: an effectiveness and cost-effectiveness analysis.
    Savinkina A; Madushani RWMA; Eftekhari Yazdi G; Wang J; Barocas JA; Morgan JR; Assoumou SA; Walley AY; Linas BP; Murphy SM
    Addiction; 2022 Sep; 117(9):2450-2461. PubMed ID: 35315162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimated Costs and Outcomes Associated With Use and Nonuse of Medications for Opioid Use Disorder During Incarceration and at Release in Massachusetts.
    Chatterjee A; Weitz M; Savinkina A; Macmadu A; Madushani RWMA; Potee RA; Ryan D; Murphy SM; Walley AY; Linas BP
    JAMA Netw Open; 2023 Apr; 6(4):e237036. PubMed ID: 37058306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Public Health Interventions and Overdose-Related Outcomes Among Persons With Opioid Use Disorder.
    Nataraj N; Rikard SM; Zhang K; Jiang X; Guy GP; Rice K; Mattson CL; Gladden RM; Mustaquim DM; Illg ZN; Seth P; Noonan RK; Losby JL
    JAMA Netw Open; 2024 Apr; 7(4):e244617. PubMed ID: 38568691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Black clients in expansion states who used opioids were more likely to access medication for opioid use disorder after ACA implementation.
    Johnson NL; Choi S; Herrera CN
    J Subst Abuse Treat; 2022 Feb; 133():108533. PubMed ID: 34218991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simulated impact of medicaid expansion on the economic burden of opioid use disorder in North Carolina.
    Barbosa C; Dowd WN; Buell N; Allaire B; Bobashev G
    Int J Drug Policy; 2024 Jun; 128():104449. PubMed ID: 38733650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Medicaid Expansion With Opioid Overdose Mortality in the United States.
    Kravitz-Wirtz N; Davis CS; Ponicki WR; Rivera-Aguirre A; Marshall BDL; Martins SS; Cerdá M
    JAMA Netw Open; 2020 Jan; 3(1):e1919066. PubMed ID: 31922561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Sick and tired of being sick and tired": Exploring initiation of medications for opioid use disorder among people experiencing homelessness.
    Swartz N; Adnan T; Peréa F; Baggett TP; Chatterjee A
    J Subst Abuse Treat; 2022 Jul; 138():108752. PubMed ID: 35277306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "They make it too hard and too many hoops to jump": system and organizational barriers to drug treatment during epidemic rates of opioid overdose.
    Dickson-Gomez J; Krechel S; Ohlrich J; Montaque HDG; Weeks M; Li J; Havens J; Spector A
    Harm Reduct J; 2024 Feb; 21(1):52. PubMed ID: 38413972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of medications for opioid use disorder with reduced risk of repeat opioid overdose in Medicaid: A cohort study.
    Tipping AD; Nowels M; Moore C; Samples H; Crystal S; Olfson M; Williams AR; Heaps-Woodruff J
    J Subst Use Addict Treat; 2024 Feb; 157():209218. PubMed ID: 37984564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simulating the experience of searching for LGBTQ-specific opioid use disorder treatment in the United States.
    Paschen-Wolff MM; Velasquez R; Aydinoglo N; Campbell ANC
    J Subst Abuse Treat; 2022 Sep; 140():108828. PubMed ID: 35749919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of the implementation of medication for opioid use disorder and COVID-19 in a statewide correctional system on treatment engagement, postrelease continuation of care, and overdose.
    Klemperer EM; Wreschnig L; Crocker A; King-Mohr J; Ramniceanu A; Brooklyn JR; Peck KR; Rawson RA; Evans EA
    J Subst Use Addict Treat; 2023 Sep; 152():209103. PubMed ID: 37311520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are North Carolina clinicians delivering opioid use disorder treatment to Medicaid beneficiaries?
    Grove LR; Rao N; Domino ME
    Addiction; 2022 Nov; 117(11):2855-2863. PubMed ID: 35194878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coverage and Prior Authorization Policies for Medications for Opioid Use Disorder in Medicaid Managed Care.
    Abraham AJ; Andrews CM; Harris SJ; Westlake MM; Grogan CM
    JAMA Health Forum; 2022 Nov; 3(11):e224001. PubMed ID: 36331441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid overdose survivors: Medications for opioid use disorder and risk of repeat overdose in Medicaid patients.
    Crystal S; Nowels M; Samples H; Olfson M; Williams AR; Treitler P
    Drug Alcohol Depend; 2022 Mar; 232():109269. PubMed ID: 35038609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations Between Inpatient Induction on Medications for Opioid Use Disorder and Postdischarge Medications for Opioid Use Disorder Adherence, Overdose, and Service Use.
    Noam KR; Schmutte TJ; Pirard S; Bourdon C; Langless D; Plant R
    J Addict Med; 2023 May-Jun 01; 17(3):e199-e201. PubMed ID: 37267183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between treatment setting and outcomes among oregon medicaid patients with opioid use disorder: a retrospective cohort study.
    Hartung DM; Markwardt S; Johnston K; Geddes J; Baker R; Leichtling G; Hildebran C; Chan B; Cook RR; McCarty D; Ghitza U; Korthuis PT
    Addict Sci Clin Pract; 2022 Aug; 17(1):45. PubMed ID: 35986384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the impact on initiating medications for opioid use disorder of state policies expanding Medicaid and prohibiting substance use during pregnancy.
    Choi S; Stein MD; Raifman J; Rosenbloom D; Clark JA
    Drug Alcohol Depend; 2021 Dec; 229(Pt A):109162. PubMed ID: 34768053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Medicaid expansion on inclusion of medications for opioid use disorder in homeless adults' treatment plans.
    Swartz N; Odayappan S; Chatterjee A; Cutler D
    J Subst Use Addict Treat; 2023 Sep; 152():209059. PubMed ID: 37207834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.